2021
DOI: 10.1016/j.canlet.2021.07.025
|View full text |Cite
|
Sign up to set email alerts
|

Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
46
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(47 citation statements)
references
References 50 publications
0
46
1
Order By: Relevance
“…On the other hand, Fascin (FSCN1)—an actin filament bundling protein—was significantly overexpressed in SqCC tissue compared to the other cancer types. The overexpression of FSCN1 in NSCLC has been previously reported to be associated with tumor growth, migration, invasion, and metastasis [ 45 , 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, Fascin (FSCN1)—an actin filament bundling protein—was significantly overexpressed in SqCC tissue compared to the other cancer types. The overexpression of FSCN1 in NSCLC has been previously reported to be associated with tumor growth, migration, invasion, and metastasis [ 45 , 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…Functionally, Fascin contributes to the migration and invasion of cancer cells and is thereby crucial for stability and formation of specialized protrusive structures, socalled invadopodia [63]. Transcriptional regulation of Fascin is heterogeneous between different cell types, tissues, and tumors [63,64]. We have previously shown that a single viral oncoprotein, Tax-1 of HTLV-1, is a potent inducer of Fascin in T-cells depending on classical NF-κB signaling [36,41].…”
Section: Discussionmentioning
confidence: 99%
“…There is previous evidence in the literature of FSCN1 involvement in tumor metabolism. In lung cancer, FSCN1 promotes cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression through YAP1 activation [ 36 ]. In the context of PIK3CA mutation or amplification, high expression of FSCN1 is associated with poor prognosis and radiotherapy response in cancer patients; mutant PIK3CA (E542K and E545K) can enhance glucose metabolism and cell proliferation in cancer cells [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%